Drugs Of Abuse (DOA) Testing Global Market Size is Expected to Reach $10.48 Billion at a CAGR of 9.6% By 2028 | Natera Inc., NMS Labs, Premier Biotech Inc., Siemens AG

Spread the love

Overview and Scope
Drug of abuse (DOA) testing refers to the examination of a substance, such as a drug, chemical, or plant product, that is usually treated recreationally. It includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are tested for on a drug panel. The patient’s urine, saliva, blood, hair, or sweat are used in this clinical screening procedure.

Sizing and Forecast
The drugs of abuse (DOA) testing market size has grown strongly in recent years. It will grow from $6.6 billion in 2023 to $7.25 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to government regulations and workplace policies, pre-employment screening, law enforcement and legal procedures, drug rehabilitation programs, transportation industry compliance.

The drugs of abuse (DOA) testing market size is expected to see strong growth in the next few years. It will grow to $10.48 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to expanding sports and athletics testing, increasing awareness and education, rise in drug-related crimes, corporate wellness programs, advancements in testing methods. Major trends in the forecast period include use of portable and handheld testing devices, implementation of laboratory information management systems (LIMS), emphasis on synthetic drug testing, increasing demand for cannabis testing, integration of artificial intelligence (AI) for result interpretation.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

Segmentation & Regional Insights
The drugs of abuse (DOA) testing market covered in this report is segmented –
1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services
2) By Sample Type: Urine, Hair, Oral Fluid, Breath
3) By Application: Pain Management, Criminal Justice, Workplace Screening
4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users

North America was the largest region in the drugs of abuse (DOA) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp

Major Driver Impacting Market Growth
Increasing demand for drug abuse treatment is expected to propel the growth of the drugs of abuse (DOA) testing market going forward. Drug abuse or substance abuse refers to the use of a substance in quantities that are harmful to the user or others. Drug testing aids in the identification of compounds that are not normally found in the body. The process starts with a screening test, which is followed by a second test to find and/or confirm the presence of a substance or substances, so increasing demand for drug abuse treatment will propel the market’s growth. For instance, in June 2021, according to the United Nations Office on Drugs and Crime (UNODC), a US-based drug control and crime prevention organization, combining the United Nations International Report 2021 World Drug Report, over 36 million individuals in the world have drug use disorders. Therefore, increasing demand for drug abuse treatment is driving the drug of abuse (DOA) testing market.

Key Industry Players
Major companies operating in the drugs of abuse (DOA) testing market report are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Zimmer Biomet Holdings Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Natera Inc., Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., Homology Medicines Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

The drugs of abuse (doa) testing market report table of contents includes:
1. Executive Summary